Statins: are any questions unanswered?

Related Experiment Video

Updated: Aug 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Patricia M Kearney1, Colin Baigent

  • 1Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford, UK.

Current Opinion in Lipidology
|July 13, 2006
PubMed
Abstract

Insights

Statin therapy effectively prevents major vascular events in many patients. Ongoing research explores optimal dosing and benefits in specific conditions like advanced kidney disease.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Cardiovascular disease remains a leading cause of mortality worldwide.
  • Statins are widely prescribed lipid-lowering drugs for cardiovascular risk reduction.
  • Evidence continues to evolve regarding the optimal use of statin therapy.

Purpose of the Study:

  • To review recent and ongoing randomized trials on statin therapy.
  • To assess the efficacy of statins in preventing major vascular events.
  • To identify current uncertainties in statin therapy application.

Main Methods:

  • Systematic review of large-scale randomized controlled trials.
  • Analysis of comparative effectiveness of high-dose versus standard-dose statins.
  • Evaluation of statin benefits across diverse patient populations and comorbidities.

Main Results:

  • Higher statin doses demonstrate increased efficacy in preventing vascular events but with higher toxicity.
  • Statin therapy is proven effective for most patients with type 2 diabetes.
  • Efficacy in patients with advanced nephropathy requires further investigation.
  • Ongoing trials examine statin benefits in noncoronary vascular disease and specific risk factors.

Conclusions:

  • Statin therapy offers a safe and effective means to reduce vascular event risk across a broad patient spectrum.
  • Further research is needed to clarify optimal statin dosing strategies.
  • The role of statins in specific patient subgroups with complex comorbidities warrants continued study.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...